0
$0.00

Selank

Product Overview Of Selank

  • Goals: Anxiety reduction, cognitive support, mood stabilization
  • Administration: 200–500 mcg intranasally or subcutaneously, daily (research settings)
  • Cycle Length: 4–8 weeks
  • Note: A synthetic heptapeptide based on tuftsin, studied for nootropic and anxiolytic effects

Selank is a synthetic peptide derived from tuftsin, researched for its ability to reduce anxiety, support cognitive performance, and promote emotional balance in laboratory studies across Canada.

$109.99

Get Notified

Coming Early 2026!

Share On Social!

Reviews For Selank From Helixx Online

[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]
[users_name][users_handle]
[users_review]

What is Selank?

Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin. Originally developed in Russia, Selank has been studied for its nootropic, anxiolytic, and neuroprotective properties. It is often researched for its ability to modulate neurotransmitters such as serotonin and dopamine, while also influencing the immune system.

How Does Selank Work?

Selank interacts with the central nervous system by influencing monoamine neurotransmitters, enhancing serotonin metabolism, and modulating GABAergic signaling. It has also been studied for upregulating brain-derived neurotrophic factor (BDNF), a protein essential for neuroplasticity and cognitive function. These mechanisms may explain its reported benefits for anxiety reduction, improved memory, and mood stabilization.

Chemical Properties

Chemical Name Thr-Lys-Pro-Arg-Pro-Gly-Pro
CAS Number 129954-34-3
Molecular Formula C33H57N11O9
Molecular Weight 751.9 g/mol
Peptide Class Nootropic / Anxiolytic Peptide

Potential Benefits of Selank

  • Anxiety Reduction: Studied for its calming, anxiolytic effects without sedation.
  • Cognitive Enhancement: May support learning, memory, and focus.
  • Mood Stabilization: Supports emotional balance through serotonin regulation.
  • Immune Modulation: Early research suggests effects on immune response and stress adaptation.

Clinical Research & Findings

Research conducted in Russia and other regions highlights Selank’s potential as a non-sedating anxiolytic with additional nootropic properties. Preclinical studies show improvements in stress resilience, cognitive performance, and BDNF expression. Limited human studies suggest it may reduce symptoms of generalized anxiety and enhance mental clarity, though more global research is needed.

Dosage & Research Protocols

  • Research Dose: 200–500 mcg daily
  • Administration: Intranasal spray or subcutaneous injection
  • Cycle Length: 4–8 weeks

Dosing varies depending on the research focus (cognitive vs. anxiolytic outcomes). Intranasal delivery is commonly studied for its rapid absorption.

FAQs

Is Selank legal in Canada?

Yes. Selank is legal for research use in Canada but is not approved for human consumption.

What are the main research applications of Selank?

Selank is studied for anxiety reduction, nootropic effects, mood stabilization, and immune modulation.

How is Selank administered?

Research typically explores intranasal spray or subcutaneous injection as delivery methods.

Does Selank cause drowsiness?

No. Unlike sedatives, Selank is researched as a non-sedating anxiolytic peptide.

Disclaimer

For laboratory use only. Not for human or veterinary use.

This peptide is intended strictly for research under controlled laboratory conditions. Buyers are responsible for ensuring legal and ethical compliance with institutional, local, and federal regulations.


0